UK biotech firm Autolus joins CAR-T rush with Nasdaq IPO filing: Reuters

Autolus Therapeutics, a small British company developing cell therapy treatments, is to join the swelling ranks of listed biotech companies using the new anti-cancer technology with a planned IPO on Nasdaq, Reuters reported.